Osteopathic Single CAse Research for Patients With Chronic Low Back Pain (OSCAR)

April 23, 2025 updated by: University College of Osteopathy

OSCAR (Osteopathic Single CAse Research) - Assessing the Effects of Standard and Biopsychosocially-informed Osteopathic Management for Patients With Non-specific Low Back Pain: A Single Case Experimental Design (SCED)

This study aims to collect primary data from patients with low back pain to assess the effect of standard osteopathic management and biopsychosocially-informed osteopathic care using a Single-Case Experimental Design.

Study Overview

Detailed Description

After being informed about the study and potential risks, all osteopaths and patient participants giving written consent will be screened for eligibility. When entering the trial, patients will be randomised to early, intermediate or late intervention with either standard osteopathic management or biopsychosocially-informed osteopathic management.

Study Type

Interventional

Enrollment (Actual)

9

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • London, United Kingdom, SE1 1JE
        • University College of Osteopathy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 or more years old
  • agree to take part in the study and provide formal online consent after having been assessed as capable of providing informed consent by the osteopath
  • Being fluent enough in English to be able to understand content of consent forms (and participate in osteopathic treatment without an interpreter)
  • Presenting with non-specific low back pain of a duration of a minimum of 12 weeks)
  • NRS score between 5 and 9 on a 11-point scale
  • PSFS score between 2 and 7 at baseline
  • Who can be contacted by email
  • Available for an appointment within two days around the randomisation date

Exclusion Criteria:

  • Under 18
  • Lacking capacity to give consent
  • Presenting with low back pain with a known or suspected pathological cause (e.g. infection, cancer or fracture)
  • People for whom osteopathic treatment may be contra-indicated (as assessed by the osteopath in the initial consultation) or who disclose information during their course of treatment which requires referral for other medical investigations or care
  • LBP of less than 12 weeks
  • NRS score below 5 or above 9
  • PSFS score above below 2 or above 7
  • Patients providing less than 3 data points during baseline

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: standard osteopathic manual treatment
Pragmatic individualised osteopathic manual treatment which is a system of diagnosis and treatment for a wide range of musculoskeletal conditions. Osteopaths take a detailed case history and perform a thorough clinical examination to help understand the nature of patients' pain and symptoms so that they can arrive at a diagnosis. Practitioners use touch, physical manipulation, stretching and massage to help increase the mobility of joints, to relieve muscle/joint tension and pain. Osteopaths often combine a range of other treatment techniques in their approach, such as rehabilitative exercises, advice about how patients can self-manage their condition and educational approaches to help them understand their pain. Osteopathy is a regulated profession (regulated by the General Osteopathic Council) in the UK
includes touch, joint manipulations, stretching and massage
Other Names:
  • Osteopathic Manipulative Technique
Providing rehabilitative exercises to patients to do at home
Other Names:
  • Therapeutic exercises
Reassuring patients on their symptoms, diagnosis and prognosis.
Other Names:
  • cognitive reassurance; affective reassurance
Active Comparator: biopsychosocially informed osteopathic manual treatment
As for the active comparator + biopsychosocial management: after having a completed a 8-10 hour e-learning on the biopsychosocial model for the management of low back pain, osteopaths will use the same approaches as in the active comparator group, plus techniques to help patients making sense of their symptoms, to develop patients' self-efficacy, and psychosocial management skills.
includes touch, joint manipulations, stretching and massage
Other Names:
  • Osteopathic Manipulative Technique
Providing rehabilitative exercises to patients to do at home
Other Names:
  • Therapeutic exercises
Reassuring patients on their symptoms, diagnosis and prognosis.
Other Names:
  • cognitive reassurance; affective reassurance
Giving a central place to the patient in the decision-making to help them to get back to valued activities.
Other Names:
  • Enactive approach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale changes during the treatment phase (max 6 weeks) and follow-up period (12 weeks)
Time Frame: Up to 18 weeks
11-item unidimensional measure of pain intensity. The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendations will be used, i.e. patients will be presented with the numbers from 0 to 10, with 0 meaning 'No pain' and '10' meaning 'Pain as bad as you can imagine,' accompanied by the instructions "Please rate your pain by indicating the number that best describes your pain on average in the last 24h". NPRS is an acceptable measure but should not be used on its own as patients with chronic pain find it does not capture the complexity of their pain experience. It has a high test-retest reliability and a good validity. Patients will be asked to complete the NPRS every day, taking approx. 1 min.
Up to 18 weeks
The Patient Specific Functional Scale changes during the treatment phase (max 6 weeks) and follow-up period (12 weeks)
Time Frame: Up to 18 weeks
PSFS measures functional change in patients with musculoskeletal disorders. Patients choose to list up to 5 activities that they have difficulty with or are unable to perform. They will be asked to continue recording data for the originally chosen activities but can add extra activities if goals change (e.g. due to improving or worsening symptoms). Patients will rate current level of difficulty for each activity on an 11-point scale, where 0 = unable to perform and 10 = able to perform at previous level. Mean averages are calculated by summing the difficulty ratings and dividing by the number of activities. The PSFS is reliable and responsive for patients with chronic low back pain and a Minimum Detectable Change (MDC) is considered to be 3 points for 1 activity or 2 points for the average of 2 or more activities.
Up to 18 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure Your Medical Outcome Profile 2
Time Frame: Up to 18 weeks
MYMOP2 is a self-report questionnaire that lists one or two symptoms and one activity affected by the patient's condition. The first activity the patient participant created in PSFS will automatically be entered into the text of MYMOP2. The follow-up questionnaire is shorter but allows addition of a third symptom. MYMOP2 is a validated, sensitive and responsive outcome measure. A minimum clinically important change (MCIC) in score should be between 0.5-1.0, and any change greater than 1.0 is considered clinically significant. Patients will be asked to complete MYMOP2 once a week, taking approx. 5 min.
Up to 18 weeks
The Arthritis Research UK Musculoskeletal Health Questionnaire
Time Frame: Up to 18 weeks
MSK-HQ captures generalised health outcomes that are relevant to patients with a range of musculoskeletal conditions. It achieves high completion rates, excellent test-retest reliability, and has strong convergent validity with reference standards. It includes 14 questions scored on a 0-4 scale (range 0-56, where a higher total score represents better health). A licence has been requested to use the questionnaire online from Oxford University Innovation centre for free. Patients will be asked to complete the MSK-HQ three times, taking approx. 2 minutes.
Up to 18 weeks
The Depression, Anxiety, and Positive Outlook Scale
Time Frame: Up to 18 weeks
DAPOS is a self-administered questionnaire that measures distress and positive affect in chronic musculoskeletal pain populations. It has 11 items: 5 on depression, 3 on positive affect and 3 on anxiety; all answered with a 5-point Likert scale response (ranging from 'almost never' to 'almost all the time'). It has an excellent internal consistency and construct validity in comparison with a variety of measures (SF-36; Pain Catastrophizing Scale; Zung Depression) and an acceptable responsiveness.
Up to 18 weeks
The Pain Attitudes and Beliefs Scale (for the osteopaths)
Time Frame: 6 months
PABS is a 19-item questionnaire with six-point response scales. The questionnaire aims to assess two treatment orientations towards LBP: 'biomedical', where disability and pain are consequences of specific tissue pathology and treatment aims to treat pathology; and 'behavioural', where practitioners believe in a BPS model of disease, in which pain does not have to be a sign of tissue damage and can be influenced by social and psychological factors. There is evidence for content and construct validity, internal consistency, reliability and responsiveness. The modified version of the PABS will be used in this project (Cronbach's α Biomedical domain 0.84; Cronbach's α behavioural domain is 0.68).
6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survey about experience of osteopathic treatment and of participating in the SCED study (for patients)
Time Frame: 6 weeks
At the end of their course of treatment, patients will be asked to complete a final. This questionnaire has been adapted from the Patient Enablement Index for Back Pain and contains 12 questions to assess patients' perceptions of shared decisions making, treatment outcomes, relevance of the measures and acceptability of the data collection processes.
6 weeks
Prognostic surveys (for the osteopaths)
Time Frame: 6 weeks
Osteopaths will fill in two surveys, one after the initial visit of a patient and one 6 weeks later. It was previously used to assess physical therapists' ability to accurately prognose their patients.
6 weeks
Survey of SCED feasibility and acceptability and impact of the e-learning course on patient care (for the osteopaths)
Time Frame: 9 months
It was adapted from the Patient Enablement Index. It consists of 12 questions with 11-point Likert scale response options for agreement and satisfaction and 2 open text questions about osteopaths' experiences of SCED processes and outcomes to guide future training and research, taking approx. 5 minutes.
9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Jerry RF Draper-Rodi, D.Prof.(Ost), University College of Osteopathy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 5, 2021

Primary Completion (Actual)

July 31, 2023

Study Completion (Actual)

July 31, 2023

Study Registration Dates

First Submitted

October 21, 2021

First Submitted That Met QC Criteria

November 2, 2021

First Posted (Actual)

November 16, 2021

Study Record Updates

Last Update Posted (Actual)

April 27, 2025

Last Update Submitted That Met QC Criteria

April 23, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • OSCAR_LBP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Dataset will be made available with the publication or by email request to the PI

IPD Sharing Time Frame

From publication of the results and up to 6 years after trial completion.

IPD Sharing Access Criteria

Researchers who provide a methodologically sound proposal. Proposals should be directed to jerry.draper-rodi@uco.ac.uk To gain access, data requestors will need to sign a data access agreement.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low-back Pain

Clinical Trials on Osteopathic Manual Treatment

Subscribe